Literature DB >> 16840762

Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Gabriel M Leung1, Pauline P S Woo, Sarah M McGhee, Annie N Y Cheung, Susan Fan, Oscar Mang, Thuan Q Thach, Hextan Y S Ngan.   

Abstract

OBJECTIVE: To examine the secular effects of opportunistic screening for cervical cancer in a rich, developed community where most other such populations have long adopted organised screening. DESIGN, SETTING, AND PARTICIPANTS: The analysis was based on 15 140 cases of invasive cervical cancer from 1972 to 2001. The effects of chronological age, time period, and birth cohort were decomposed using both maximum likelihood and Bayesian methods.
RESULTS: The overall age adjusted incidence decreased from 24.9 in 1972-74 to 9.5 per 100,000 in 1999-2001, in a log-linear fashion, yielding an average annual reduction of 4.0% (p<0.001) during the 30 year period. There were two second order and thus identifiable changes: (1) around the mid-1920s cohort curve representing an age-period interaction masquerading as a cohort change that denotes the first availability of Pap testing during the 1960s concentrated among women in their 40s; (2) a hook around the calendar years 1982-83 when cervical cytology became a standard screening test for pregnant women.
CONCLUSIONS: Hong Kong's cervical cancer rates have declined since Pap tests first became available in the 1960s, most probably because of increasing population coverage over time and in successive generations in a haphazard fashion and punctuated by the systematic introduction of routine cytology as part of antenatal care in the 1980s.

Entities:  

Mesh:

Year:  2006        PMID: 16840762      PMCID: PMC2588081          DOI: 10.1136/jech.2005.042275

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  30 in total

1.  Cervical cancer screening programme in Finland.

Authors:  A Anttila; P Nieminen
Journal:  Eur J Cancer       Date:  2000-11       Impact factor: 9.162

2.  Rates of cesarean births in Hong Kong: 1987-1999.

Authors:  G M Leung; T H Lam; T Q Thach; S Wan; L M Ho
Journal:  Birth       Date:  2001-09       Impact factor: 3.689

3.  Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types.

Authors:  Paul K S Chan; Alexander R Chang; Jo L K Cheung; Denise P C Chan; L Y Xu; Nelson L S Tang; Augustine F Cheng
Journal:  J Infect Dis       Date:  2001-12-05       Impact factor: 5.226

4.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas.

Authors:  A P Vizcaino; V Moreno; F X Bosch; N Muñoz; X M Barros-Dios; D M Parkin
Journal:  Int J Cancer       Date:  1998-02-09       Impact factor: 7.396

5.  Evaluation of birth cohort patterns in population disease rates.

Authors:  R E Tarone; K C Chu
Journal:  Am J Epidemiol       Date:  1996-01-01       Impact factor: 4.897

6.  Age, period and cohort models applied to cancer mortality rates.

Authors:  C Osmond; M J Gardner
Journal:  Stat Med       Date:  1982 Jul-Sep       Impact factor: 2.373

7.  Trends in mammography and Pap smear utilization in Canada.

Authors:  J Snider; J Beauvais; I Levy; P Villeneuve; J Pennock
Journal:  Chronic Dis Can       Date:  1996

8.  International trends in incidence of cervical cancer: II. Squamous-cell carcinoma.

Authors:  A P Vizcaino; V Moreno; F X Bosch; N Muñoz; X M Barros-Dios; J Borras; D M Parkin
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

9.  Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89.

Authors:  T Zheng; S T Mayne; T R Holford; P Boyle; W Liu; Y Chen; M Mador; J Flannery
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

10.  Increasing cancer risk in younger birth cohorts in Sweden.

Authors:  H O Adami; R Bergström; P Sparén; J Baron
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

View more
  7 in total

1.  How does socioeconomic development affect COPD mortality? An age-period-cohort analysis from a recently transitioned population in China.

Authors:  Jing Chen; Catherine Mary Schooling; Janice Mary Johnston; Anthony Johnson Hedley; Sarah Morag McGhee
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

2.  Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.

Authors:  P P S Woo; T Q Thach; S T B Choy; S M McGhee; G M Leung
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

3.  Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012.

Authors:  Fangfang Chen; Dingyong Sun; Yuming Guo; Wei Guo; Zhengwei Ding; Peilong Li; Jie Li; Lin Ge; Ning Li; Dongmin Li; Lu Wang; Zhe Wang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

4.  Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis.

Authors:  Jinyao Wang; Zhiqiang Bai; Zhenkun Wang; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2016-11-17       Impact factor: 3.390

5.  Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea.

Authors:  Eun-Kyeong Moon; Chang-Mo Oh; Young-Joo Won; Jong-Keun Lee; Kyu-Won Jung; Hyunsoon Cho; Jae Kwan Jun; Myong Cheol Lim; Moran Ki
Journal:  Cancer Res Treat       Date:  2016-09-01       Impact factor: 4.679

6.  Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.

Authors:  Ke Li; Huan Xu; Suixiang Wang; Pengzhe Qin; Boheng Liang
Journal:  BMC Cancer       Date:  2022-04-15       Impact factor: 4.638

7.  Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess.

Authors:  Xiaoduo Wen; Denggui Wen; Yi Yang; Yuetong Chen; Kohei Akazawa; Yunjiang Liu; Baoen Shan
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.